{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:39:10Z","timestamp":1792949950503,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102369","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:14:20Z","timestamp":1758831260000},"page":"102369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques"],"prefix":"10.1016","volume":"6","author":[{"given":"Tiffany M.","family":"Styles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akil","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine S.","family":"McPartlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poulami","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrik","family":"Gratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey","family":"Stokdyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alesandra J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumathi","family":"Loganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anass","family":"Abbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghania","family":"Chikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui S.","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasdave S.","family":"Chahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6309-6797","authenticated-orcid":false,"given":"Rama R.","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102369_bib1","article-title":"Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines","volume":"10","author":"Trombetta","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.xcrm.2025.102369_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.xcrm.2025.102369_bib3","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1073\/pnas.79.15.4800","article-title":"Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes","volume":"79","author":"Krystal","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102369_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0042-6822(83)90465-8","article-title":"Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants","volume":"126","author":"Graves","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2025.102369_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-019-0147-z","article-title":"Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts","volume":"4","author":"Nachbagauer","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xcrm.2025.102369_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI123366","article-title":"Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem","volume":"129","author":"Tan","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102369_bib8","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/infdis\/jiy696","article-title":"Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens","volume":"219","author":"Zost","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.102369_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chom.2015.10.003","article-title":"The Quest for a Universal Flu Vaccine: Headless HA 2.0","volume":"18","author":"Krammer","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2025.102369_bib10","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib11","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xcrm.2025.102369_bib13","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib14","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib15","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102369_bib16","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102369_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102369_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model","volume":"91","author":"Ermler","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling influenza with broadly neutralizing antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314905120","article-title":"Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgammaR-dependent protection in vivo","volume":"120","author":"Edgar","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102369_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102369_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102369_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.102369_bib24","article-title":"New Kids on the Block: RNA-Based Influenza Virus Vaccines","volume":"6","author":"Scorza","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.xcrm.2025.102369_bib25","first-page":"111","article-title":"Messenger RNA-Based Vaccines Against Infectious Diseases","volume":"440","author":"Alameh","year":"2022","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102369_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112884","article-title":"Self-Amplifying RNA Approach for Protein Replacement Therapy","volume":"23","author":"Papukashvili","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102369_bib28","article-title":"An Update on Self-Amplifying mRNA Vaccine Development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.xcrm.2025.102369_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102369_bib30","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102369_bib31","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1093\/nar\/gkr586","article-title":"Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L","volume":"39","author":"Anderson","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102369_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib33","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102369_bib34","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design","volume":"198","author":"Pepini","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-6481-9_6","article-title":"Nucleoside Modified mRNA Vaccines for Infectious Diseases","volume":"1499","author":"Pardi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102369_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2025.102369_bib38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102369_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/JVI.01786-15","article-title":"Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin","volume":"90","author":"Brazzoli","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add3075","article-title":"Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells","volume":"7","author":"Kunzli","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.xcrm.2025.102369_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fimmu.2019.00965","article-title":"Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle","volume":"10","author":"Lightman","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102369_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aaz8432","article-title":"Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination","volume":"370","author":"Davis","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102369_bib45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","article-title":"SARS-CoV-2 Omicron boosting induces de novo B cell response in humans","volume":"617","author":"Alsoussi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102369_bib46","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1038\/s41467-021-23942-y","article-title":"SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung","volume":"12","author":"Routhu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102369_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00934-19","article-title":"Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA\/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge","volume":"93","author":"Styles","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh3034","article-title":"PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8(+) T cells in lymphoid tissue","volume":"6","author":"Rahman","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00505-17","article-title":"Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison","volume":"86","author":"Maiello","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2025.102369_bib50","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"Johnson","year":"1995","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.xcrm.2025.102369_bib51","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1016\/j.vaccine.2017.09.052","article-title":"Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system","volume":"35","author":"Cheng","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2025.102369_bib52","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.200408-1078OC","article-title":"Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA","volume":"171","author":"Suzuki","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2025.102369_bib54","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102369_bib55","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.4049\/jimmunol.174.5.2942","article-title":"Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88","volume":"174","author":"Hasan","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib56","first-page":"170","article-title":"Mouse models of human disease: An evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol. Med. Public Health"},{"key":"10.1016\/j.xcrm.2025.102369_bib57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","article-title":"Preclinical research: Make mouse studies work","volume":"507","author":"Perrin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102369_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000245","article-title":"Can animal models of disease reliably inform human studies?","volume":"7","author":"van der Worp","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.xcrm.2025.102369_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1196\/annals.1354.010","article-title":"Aging in mouse and human systems: a comparative study","volume":"1067","author":"Demetrius","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.xcrm.2025.102369_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1474-9726.2006.00262.x","article-title":"Telomerase activity coevolves with body mass not lifespan","volume":"6","author":"Seluanov","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2025.102369_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cvex.2009.12.002","article-title":"The senior ferret (Mustela putorius furo)","volume":"13","author":"Hoppes","year":"2010","journal-title":"Vet. Clin. North Am. Exot. Anim. Pract."},{"key":"10.1016\/j.xcrm.2025.102369_bib62","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2019.0612","article-title":"Rhesus macaques as a tractable physiological model of human ageing","volume":"375","author":"Chiou","year":"2020","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.xcrm.2025.102369_bib63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ygeno.2017.04.001","article-title":"Whole genome sequencing predicts novel human disease models in rhesus macaques","volume":"109","author":"Bimber","year":"2017","journal-title":"Genomics"},{"key":"10.1016\/j.xcrm.2025.102369_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri2357","article-title":"Impact of MHC class I diversity on immune control of immunodeficiency virus replication","volume":"8","author":"Goulder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41541-022-00590-x","article-title":"A phase I\/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine","volume":"7","author":"Low","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xcrm.2025.102369_bib66","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib67","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice","volume":"53","author":"Laczko","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib68","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102369_bib69","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19","volume":"384","author":"Doria-Rose","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102369_bib70","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102369_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102476","article-title":"Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping","volume":"4","author":"Turner","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2025.102369_bib72","article-title":"Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody","volume":"62","author":"Ali","year":"2018","journal-title":"Treating Acute Uncomplicated Influenza"},{"key":"10.1016\/j.xcrm.2025.102369_bib73","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102369_bib74","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4049\/jimmunol.1500083","article-title":"Codelivery of Envelope Protein in Alum with MVA Vaccine Induces CXCR3-Biased CXCR5+ and CXCR5- CD4 T Cell Responses in Rhesus Macaques","volume":"195","author":"Iyer","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102369_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftz044","article-title":"Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors","volume":"77","author":"Swathirajan","year":"2019","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.xcrm.2025.102369_bib77","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1073\/pnas.1810927115","article-title":"Influenza hemagglutinin membrane anchor","volume":"115","author":"Benton","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102369_bib78","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","article-title":"Broadly neutralizing antibodies target a haemagglutinin anchor epitope","volume":"602","author":"Guthmiller","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102369_bib79","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V75.6.1305.1305","article-title":"Interleukin-1 induces interleukin-6 production in peripheral blood monocytes","volume":"75","author":"Tosato","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102369_bib80","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/343341a0","article-title":"Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist","volume":"343","author":"Eisenberg","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102369_bib82","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/343336a0","article-title":"Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor","volume":"343","author":"Hannum","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102369_bib83","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cytogfr.2020.06.008","article-title":"IL-15 immunotherapy is a viable strategy for COVID-19","volume":"54","author":"Kandikattu","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.xcrm.2025.102369_bib84","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102369_bib85","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/s41467-022-31005-z","article-title":"Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection","volume":"13","author":"Rappaport","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102369_bib86","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2025.102369_bib88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","article-title":"Germinal centre-driven maturation of B cell response to mRNA vaccination","volume":"604","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102369_bib89","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102369_bib90","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo","volume":"14","author":"Le Bon","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib91","article-title":"A Role for the Chicken Interferon-Stimulated Gene CMPK2 in the Host Response Against Virus Infection","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2025.102369_bib92","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib93","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.bbrc.2017.12.014","article-title":"Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1)","volume":"496","author":"Kim","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102369_bib94","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1186\/s12885-018-5117-8","article-title":"CCL1 is a major regulatory T cell attracting factor in human breast cancer","volume":"18","author":"Kuehnemuth","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.102369_bib95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrrheum.2015.161","article-title":"Targeting GM-CSF in inflammatory diseases","volume":"12","author":"Wicks","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.xcrm.2025.102369_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2025.102369_bib97","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.xcrm.2025.102369_bib98","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/ATVBAHA.110.207464","article-title":"Suppressors of cytokine signaling (SOCS) proteins and JAK\/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3","volume":"31","author":"Tamiya","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2025.102369_bib99","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib100","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102369_bib101","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V86.2.685.bloodjournal862685","article-title":"Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma","volume":"86","author":"Bataille","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102369_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017739","article-title":"IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation","volume":"6","author":"Eto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.102369_bib103","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.4049\/jimmunol.176.7.4042","article-title":"Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 responsiveness, and high PRDI-BF1\/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells","volume":"176","author":"Gonzalez-Garcia","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib104","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V97.6.1817","article-title":"Interleukin-6 is a growth factor for nonmalignant human plasmablasts","volume":"97","author":"Jego","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102369_bib105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood.V94.2.701","article-title":"Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells","volume":"94","author":"Jego","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102369_bib106","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ni.2947","article-title":"The cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells","volume":"15","author":"Schmitt","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2016.06.005","article-title":"Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus","volume":"496","author":"Bhalla","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2025.102369_bib108","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1128\/JVI.01041-09","article-title":"Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff","volume":"83","author":"Simmons","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib109","article-title":"Innate immune evasion by alphaviruses","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00728-22","article-title":"Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques","volume":"96","author":"Chan","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib111","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/CVI.00547-14","article-title":"Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment","volume":"21","author":"Skinner","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3991(99)00043-1","article-title":"Leginon: a system for fully automated acquisition of 1000 electron micrographs a day","volume":"77","author":"Potter","year":"1999","journal-title":"Ultramicroscopy"},{"key":"10.1016\/j.xcrm.2025.102369_bib112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsb.2009.01.002","article-title":"Appion: an integrated, database-driven pipeline to facilitate EM image processing","volume":"166","author":"Lander","year":"2009","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.xcrm.2025.102369_bib130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","article-title":"RELION: implementation of a Bayesian approach to cryo-EM structure determination","volume":"180","author":"Scheres","year":"2012","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.xcrm.2025.102369_bib113","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.xcrm.2025.102369_bib114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-0716-3770-8_7","article-title":"Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases","volume":"2786","author":"Vadovics","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102369_bib115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA","volume":"15","author":"Baiersdorfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2025.102369_bib116","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2025.102369_bib117","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102369_bib118","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01696-18","article-title":"Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice","volume":"93","author":"Asthagiri Arunkumar","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102369_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg7015","article-title":"Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates","volume":"8","author":"Routhu","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.914969","article-title":"V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A\u221701 negative Rhesus Macaques","volume":"13","author":"Styles","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102369_bib122","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1128\/JVI.00975-14","article-title":"CD40L-adjuvanted DNA\/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge","volume":"88","author":"Kwa","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102369_bib123","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102369_bib124","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102369_bib125","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2025.102369_bib126","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2025.102369_bib127","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102369_bib129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsb.2009.01.004","article-title":"DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy","volume":"166","author":"Voss","year":"2009","journal-title":"J. Struct. Biol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:15:37Z","timestamp":1788563737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":130,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004422"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102369","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102369"}}